COSMOS Pharmaceutical Corporation
3349.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥49,538 | ¥57,038 | ¥22,765 | ¥39,129 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥770 | ¥12,240 | ¥672 | ¥683 |
| Inventory | ¥89,165 | ¥92,323 | ¥88,059 | ¥93,850 |
| Other Curr. Assets | ¥19,746 | ¥1,164 | ¥15,367 | ¥16,358 |
| Total Curr. Assets | ¥159,219 | ¥165,622 | ¥126,863 | ¥150,020 |
| Property Plant & Equip (Net) | ¥336,842 | ¥331,125 | ¥320,043 | ¥309,706 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥670 | ¥446 | ¥431 | ¥453 |
| Long-Term Investments | ¥4,397 | ¥4,464 | ¥4,428 | ¥26,391 |
| Tax Assets | ¥0 | ¥2,913 | ¥0 | ¥0 |
| Other NC Assets | ¥23,177 | ¥20,185 | ¥22,336 | ¥1 |
| Total NC Assets | ¥365,086 | ¥359,133 | ¥347,238 | ¥336,551 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥524,305 | ¥524,755 | ¥474,101 | ¥486,571 |
| Liabilities | – | – | – | – |
| Payables | ¥178,973 | ¥177,125 | ¥156,818 | ¥173,939 |
| Short-Term Debt | ¥5,482 | ¥5,682 | ¥8,006 | ¥4,331 |
| Tax Payable | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥380 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥27,184 | ¥27,177 | ¥24,163 | ¥34,563 |
| Total Curr. Liab. | ¥216,036 | ¥220,680 | ¥195,664 | ¥212,833 |
| LT Debt | ¥36,064 | ¥37,202 | ¥20,523 | ¥21,344 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥9,545 | ¥4,591 | ¥9,089 | ¥8,909 |
| Total NC Liab. | ¥45,609 | ¥46,610 | ¥29,612 | ¥30,253 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥7,073 | ¥0 | ¥0 |
| Total Liabilities | ¥261,645 | ¥267,290 | ¥225,276 | ¥243,086 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥4,178 | ¥4,178 | ¥4,178 | ¥4,178 |
| Retained Earnings | ¥253,508 | ¥248,309 | ¥239,674 | ¥234,335 |
| AOCI | ¥96 | ¥100 | ¥94 | ¥97 |
| Other Equity | ¥2 | ¥2 | ¥2 | ¥1 |
| Total Equity | ¥262,658 | ¥257,463 | ¥248,822 | ¥243,485 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥524,303 | ¥524,755 | ¥474,098 | ¥486,571 |
| Net Debt | -¥7,992 | -¥14,154 | ¥5,764 | -¥13,454 |